Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions.

Abby E RudolphFarid L KhanTanya G SinghSrinivas Rao ValluriLaura A PuzniakJohn M McLaughlin

Published in: Infectious diseases and therapy (2024)

Most patients filled their nirmatrelvir/ritonavir prescriptions. Interventions to improve uptake should focus on increasing patient and provider awareness, reducing nirmatrelvir/ritonavir prescribing disparities, and ensuring treatment initiation within 5 days.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
primary care
peritoneal dialysis
prognostic factors
emergency department
physical activity
antiretroviral therapy
patient reported outcomes
health insurance